Predictors of Pneumocystis carinii pneumonia in HIV-infected persons

American Journal of Respiratory and Critical Care Medicine

Volumn 155, Issue 1, 1997, Pages 60-66

  Stansell, John D ^a,i   Osmond, Dennis H ^a   Charlebois, Edwin ^h   Lavange, Lisa ^g   Wallace, Jeanne M ^e   Alexander, Barbara V ^h   Glassroth, Jeffrey ^b   Kvale, Paul A ^f   Rosen, Mark J ^c   Reichman, Lee B ^d   Turner, Joan R ^a   Hopewell, Philip C ^a   Merrifield, Cynthia ^a   Mossar, Melinda ^b   Hirschtick, Robert ^b   Meiselman, Lori ^c   Manghisi, Kim K ^c   Cardozo, Christopher ^c   Kalb, Thomas H ^c   Mangura, Bonita T ^d   Barnes, Saundra ^d   Shapiro, Bert ^e   LeMaire, Barbara ^e   Richer, Barbara ^e   Au, Janet ^e   Coulson, Anne ^e   Markowitz, Norman ^f   Saravolatz, Louis D ^f   Johnson, Christine ^f   Huitsing, Joanne ^f   Krystoforski, Ann Marie ^f   Kenneth Poole, W ^g   Vijaya Rao, A ^g   Clayton, Kim ^g   Hansen, Nellie I ^g   Jordan, Matthew C ^g   Thompson, Jim ^g   Myers, David ^g   Katzin, Judith ^g   Fulkerson, William ^g   Wilcosky, Tim ^g   Kalica, Anthony R ^h   Wittes, Janet ^h   Follmann, Dean A ^h   Wise, Robert ^h   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c BETH ISRAEL MEDICAL CENTER   (United States)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f HENRY FORD HOSPITAL   (United States)

^g Data Coord Ctr Res Triangle Inst   (United States)

^h San Francisco General Hospital ^*

ⁱ SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; DISEASE TRANSMISSION; FEMALE; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PNEUMOCYSTIS PNEUMONIA; PREDICTION; PRIORITY JOURNAL; RACE DIFFERENCE; RECURRENT DISEASE; RISK FACTOR; VIRUS INFECTION; VIRUS TRANSMISSION;

EID: 8044223403     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.155.1.9001290     Document Type: Article

References (12)

1. Masur, H., M. A. Micheles, J. B. Greene, I. Onorato, R. A. Stowe, R. S. Holzman, G. Wormse, L. Brettman, M. Lange, and H. M. Murray. 1981. An outbreak of community acquired Pneumocystis carinii pneumonia: initial manifestation of acquired cellular immune dysfunction. N. Engl. J. Med. 305:1431-1438.
2. Gottlieb, M. S., R. Schroff, H. M. Schanker, J. D. Weisman, P. T. Fan, R. A. Wolf, and A. Saxon. 1981. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N. Engl. J. Med. 305:1425-1431.
3. Murray, J. F., C.P. Felton, S. M. Garay, M. S. Gottlieb, P. C. Hopewell, D. E. Stover, and A. S. Teirstein. 1984. Pulmonary complications of the acquired immunodeficiency syndrome. Report of the National Heart, Lung and Blood Institute Workshop. N. Engl. J. Med. 310: 1682-1688.
4. Centers for Disease Control and Prevention. 1994. HIV/AIDS Surveillance Report. 6(No. 1):1-27.
5. Phair, J., A. Munoz, R. Detels, R. Kaslow, C. Rinaldo, and A. Saoh. 1990. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type I. N. Engl. J. Med. 322:161-165.
6. Pulmonary Complications of HIV Infection Study Group. 1990. Design of a prospective study of the pulmonary complications of human immunodeficiency virus infection. J. Clin. Epidemiol. 46:497-507.
7. Centers for Disease Control. 1986. CDC classification system for human T-lymphotrophic virus type III/lymphadenopathy-associated virus infections. M.M.W.R. 35:334-339.
8. Kalbfleisch, J. D., and R. L. Prentice. 1980. The Statistical Analysis of Failure Time Data. John Wiley and Sons, New York.
9. SAS Institute, Inc. 1987. SAS/STAT Guide for Personal Computers, 6th ed. SAS Institute, Inc., Cary, NC.
10. Centers for Disease Control. 1989. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons with human immunodeficiency virus infection. M.M.W.R. 38:1-8.
11. Kamanfu, G., N. Mlika-Cabanne, P.-M. Girard, S. Nimubona, B. Mpfizi, A. Cishako, P. Roux, J. P. Coulaud, B. Larouze, and P. Aubry. 1993. Pulmonary complications of human immunodeficiency virus infection in Bujumbura, Burundi. Am. Rev. Respir. Dis. 147: 658-663.
12. Batungwanayo, J., H. Taelman, S. Lucas, J. Bogaerts, D. Alard, A. Kagano, P. Blanche, J. Clerinx, P. van de Pelle, and S. Allen. 1994. Pulmonary disease associated with the human immunodeficiency virus in Kigali, Rwanda. Am. J. Respir. Crit. Care Med. 149:1591-1596.